DocDollars

Cleerly, Inc.

CO · United States · Reporting entity ID 100001351972

Total reported 2019–2025
$29.8M
#241 of 2,960 reporting companies — 0% of all reported industry payments
$875K in general payments across 4,019 records, plus $21.0M in research funding across 2,208 records.

How it breaks down

General payments $875,322
Research funding $20,988,302
Ownership & investment $7,954,415

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Cleerly, Inc. reported $29.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #241 of 2,960 reporting companies. 70% of that was research funding and 30% general payments such as consulting, speaking, food and travel. 4,019 general payment records and 2,208 research records were filed.

Common questions about Cleerly, Inc.

How much has Cleerly, Inc. paid US doctors?

Cleerly, Inc. reported $29,818,039 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $875,322 in general payments, $20,988,302 in research funding and $7,954,415 in ownership and investment interests.

How does Cleerly, Inc. rank among drug and device companies?

It ranks #241 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Cleerly, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.